.Nature Medication, Published online: 30 July 2024 doi:10.1038/ d41591-024-00054-wThe antibody-- drug conjugate (ADC) tisotumab vedotin led to improved progression-free as well as total survival, resulting in FDA approval and a new procedure alternative for individuals.